Overview

Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the clinical study is to evaluate the safety and bacterial impact of study drug (C16G2) administered in multiple oral gel doses to adolescent and adult dental subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Armata Pharmaceuticals, Inc.
C3 Jian, Inc.
Treatments:
Anti-Bacterial Agents
Anti-Infective Agents